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ABSTRACT
Background Long- term exposure to ambient air pollution 
leads to respiratory morbidity and mortality; however, 
the evidence of the effect on lung function and chronic 
obstructive pulmonary disease (COPD) in older adult 
populations is inconsistent.
Objective To address this knowledge gap, we investigated 
the associations between particulate matter (PM), nitrogen 
dioxide (NO2) exposure and lung function, as well as COPD 
prevalence, in older Chinese adults.
Methods We used data from the WHO Study on global 
AGEing and adult health (SAGE) China Wave 1, which 
includes 11, 693 participants from 64 townships in China. 
A cross- sectional analysis explored the association 
between satellite- based air pollution exposure estimates 
(PM with an aerodynamic diameter of ≤10 µm [PM10], 
≤2.5 µm [PM2.5] and NO2) and forced expiratory volume in 
one second (FEV1), forced vital capacity (FVC), the FEV1/
FVC ratio and COPD (defined as post- bronchodilator FEV1/
FVC <70%). Data on lung function changes were further 
stratified by COPD status.
Results Higher exposure to each pollutant was associated 
with lower lung function. An IQR (26.1 µg/m3) increase in 
PM2.5 was associated with lower FEV1 (−71.88 mL, 95% CI 
–92.13 to –51.64) and FEV1/FVC (−2.81, 95% CI −3.37 
to –2.25). For NO2, an IQR increment of 26.8 µg/m
3 was 
associated with decreases in FEV1 (−60.12 mL, 95% CI 
–84.00 to –36.23) and FVC (−32.33 mL, 95% CI –56.35 to 
–8.32). A 31.2 µg/m3 IQR increase in PM10 was linked to 
reduced FEV1 (−8.86 mL, 95% CI −5.40 to 23.11) and FEV1/
FVC (−1.85, 95% CI −2.24 to –1.46). These associations 
were stronger for participants with COPD. Also, COPD 
prevalence was linked to higher levels of PM2.5 (POR 1.35, 
95% CI 1.26 to 1.43), PM10 (POR 1.24, 95% CI 1.18 to 1.29) 
and NO2 (POR 1.04, 95% CI 0.98 to 1.11).
Conclusion Ambient air pollution was associated with 
lower lung function, especially in individuals with COPD, 
and increased COPD prevalence in older Chinese adults.
INTRODUCTION
Air pollution represents a significant public 
health threat, causing over 4 million prema-
ture deaths worldwide.1 The full list of 
medical conditions either mediated or caused 
directly by ambient air pollution is long and is 
a subject of active research.2 3 Yet some of the 
first and best- established health effects attrib-
uted to air pollution are those affecting the 
respiratory system.4 According to data from 
the Global Burden of Disease study, 43% of 
lung diseases, including lung cancer, chronic 
obstructive pulmonary disease (COPD) and 
lower respiratory infections, are attributed 
to elevated levels of air pollutants leading to 
more than 1.8 million annual deaths.5 COPD 
is one of the leading causes of death and disa-
bility globally,6 with an estimated worldwide 
prevalence of 10%.7 It has been established 
that both indoor and outdoor air pollution 
worsen COPD.7 8
A large proportion of deaths related to both 
ambient air pollution and airway diseases 
Key messages
 ► To explore and quantify the association between 
common outdoor air pollutants and chronic obstruc-
tive pulmonary disease (COPD) prevalence, as well 
as lung function, in older individuals from China with 
and without COPD.
 ► Long- term exposure to ambient particulate matter 
(with an aerodynamic diameter of ≤10 µm (PM10) 
and ≤2.5 µm (PM)2.5)) and NO2 was observed to be 
associated with a higher prevalence of COPD among 
older Chinese adults. Detrimental changes in lung 
function parameters (forced expiratory volume in 
one second (FEV
1), forced vital capacity (FVC) and 
FEV1/FVC) were also associated with increased lev-
els of PM2.5, PM10 and NO2, and were found to be 
more significant in participants with COPD.
 ► This population- based cross- sectional analysis is 
one of the first studies to suggest that people with 
COPD might be at a higher risk of decrements in lung 
function associated with ambient air pollution expo-
sure. The findings also highlight the role of outdoor 
air pollution exposure in relation to the prevalence of 
COPD among older adults from developing countries.
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occur in low- income and middle- income countries, 
where rapid economic development resulting in active 
infrastructure building, mining and urbanisation results 
in some of the highest levels of air pollution in the world.9 
China, for example, has undergone a period of rapid 
industrialisation that has resulted in massive increases 
in emissions of various air pollutants.10 According to the 
WHO database of air pollution monitoring, 283 of the 
top 500 polluted cities in the world are found in China.11 
Furthermore, the vast majority of Chinese cities fail to 
meet the air quality guidelines recommended by the 
WHO.12
Older adults are known to be more susceptible to 
the detrimental health effects of air pollution.13 This 
age group has a higher incidence and prevalence of 
chronic, progressive lung disorders, such as COPD.8 14 
These factors make older adults particularly susceptible 
to suffering from rapid urbanisation and increased air 
pollution emissions.
Although the association between ambient air pollu-
tion and impaired lung function as well as COPD seems 
logical and intuitive given the clear associations with 
a broad range of respiratory mortality and morbidity 
outcomes, the data regarding the type of pollutants and 
clinical endpoints have not been consistently measured. 
For example, air pollutants have been associated with 
various degrees of lung function impairment and COPD 
worsening in some publications,15 16 whereas others failed 
to find any significant links between the exposure and 
the outcome.17 18 The heterogeneity of the results from 
previous studies can be partially explained by variations 
in population sampling methods, exposure estimation 
techniques, and measurement and control of important 
confounders. The lack of studies coming from developing 
countries, including China, is one of the most signifi-
cant gaps in the data. To address these limitations in the 
existing literature, we aimed to investigate the long- term 
effects of outdoor air pollution on the lung function and 
COPD prevalence in a nationally representative popula-
tion of older Chinese adults.
METHODS
Study population
The WHO Study on global AGEing and adult health 
(SAGE) is a nationally representative, cross- sectional 
survey of China. Full details on the study methodology are 
available elsewhere.19 Briefly, in the SAGE China survey, 
information was collected from Chinese adult respond-
ents through an interview between 2007 and 2010.19 As a 
result of a multistage random sampling strategy, a total of 
11 693 adult participants, aged 50 years and older, were 
ultimately included in the analysis (Figure S1).
Patient involvement
The study design, analysis, interpretation of the results 
and the writing or editing of this research paper were 
made without patient involvement.
Outcome measurement
As part of SAGE China Wave 1, lung function tests were 
performed using a MIR SpiroDoc Diagnostic Portable 
Spirometer (Medical International Research, Rome, 
Italy). Participants were instructed to wear a nose clip, 
and tests were conducted in a sitting position until 
three satisfactory spirometric measurements were 
obtained.20 Forced vital capacity (FVC), forced expira-
tory volume in one second (FEV1) and the FEV1/FVC 
ratio were calculated from the averages of the three 
readings. COPD was defined as a post- bronchodilator 
FEV1/FVC less than 70%.
21
Exposure assessment
Data concentrations of particulate matter (PM) and 
nitrogen dioxide (NO2) were predicted through 
models using combined data from satellite remote 
sensing, meteorology, land use information and 
ground monitoring on the pollutants from stations 
throughout China. From 2004 to 2016, measurements 
of pollutants’ daily ground- level concentrations were 
obtained from 1479 stations of the China National 
Environmental Monitoring Centre. A detailed descrip-
tion of PM and NO2 predictions from these models has 
been published previously.22–24
Using the monitor data, 10- fold validation was applied 
to evaluate the predictive ability of the models for both 
PM and NO2. The adjusted coefficient of determina-
tion (R2) and root- mean- squared error are presented in 
online supplemental table S1.
Exposure to long- term outdoor air pollution was 
defined as the average concentration of PM and NO2 
for the 3 years (2005–2007). Lastly, we geocoded the 
community locations of participants and linked these 
to the estimated annual concentrations of PM and 
NO2.
Covariates
Demographic, behavioural and socioeconomic 
confounders and potential effect modifiers were iden-
tified a priori through a literature search.25 26 Demo-
graphic confounders included age, sex, body mass 
index (BMI) and marital status. Behavioural variables 
were smoking status (never, current, former), and 
tobacco consumption (mean daily tobacco consump-
tion), alcohol use (never or ever), fruit and vegetable 
consumption (sufficient and insufficient), and physical 
activity (low, moderate and high). Socioeconomic vari-
ables involved education level and household income. 
The level of education based on the participants’ 
self- reporting was divided into the following catego-
ries: (1) no formal education, (2) primary school, 
(3) middle school, (4) college or higher. Household 
income was categorised into two levels (low or high) 
using a median income of 15 000 Chinese yuan (¥) as 
a threshold. Additionally, we considered the place of 
residence as either urban or rural. Domestic fuel type 
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was included as an indicator of indoor air pollution. 
Two fuel types were mainly used: clean fuels, including 
electricity and natural gas, and unclean fuels, such as 
coal, wood, dung and agricultural residues.
Statistical analysis
We examined the association between lung function 
metrics and an IQR increase in 3- year moving averages of 
PM10, PM2.5 and NO2 in single pollutant models. To assess 
for potential dependence in lung function measurements 
for participants in the same community, data clustering 
was accounted using a two- level linear regression model, 
where participants were considered as the first- level unit 
and the community as the second- level unit. The effect 
estimates were expressed as absolute differences in lung 
function measures associated with each IQR (μg/m3) 
increase in ambient PM2.5, PM10 or NO2 concentrations.
For models using COPD as an outcome, logistic regres-
sion may overestimate the prevalence ratio, given a high 
prevalence of COPD in the study sample (19.5%). There-
fore, we used a modified Poisson regression with robust 
error variance to directly estimate the prevalence OR of 
COPD. In fully adjusted models, we controlled for age, 
sex, BMI, smoking status (never, current, former), tobacco 
consumption, physical activity, education level, daily fruit 
and vegetable intake, alcohol use, place of residence, 
type of fuel used at home and median annual house-
hold income. Additionally, several variables were inves-
tigated as potential effect modifiers (age, sex, smoking 
and asthma history, and household income). Interactions 
were assessed by including multiplicative terms between 
pollutant variables and several potential effect modifiers 
into the models. Significance of effect modification was 
determined if the p value for the hypothesis test of the 
interaction was <0.01.
Sensitivity analyses were performed. First, average 
pollutants concentrations were used for 1 and 5 years 
before the baseline survey to ensure that our results were 
not being driven primarily by our selection of an expo-
sure window. Second, we excluded the participants with 
cardiovascular diseases and additionally adjusted for city- 
specific covariates, such as gross domestic product (GDP) 
and percentage of the population living in urban areas. All 
analyses were conducted using STATA V.15 (StataCorp, 
College Station, Texas, USA) and p value<0.05 was used 
to determine statistical significance.
RESULTS
Characteristics for participants with complete data in 
fully adjusted lung function models are summarised in 
table 1. The mean age of participants with COPD was 
64 years, and 61 for participants without COPD. About 
51% of the participants were female, and the majority 
were living in rural areas (57%), reported never smoking 
(63%), and came from households earning less than 
¥15 000 annually (54%). Some 3.5% of study subjects 
had been previously diagnosed with asthma, and 52% 
were currently using unclean fuel at their homes. Lastly, 
COPD prevalence was 19.5%.
Online supplemental table S2, figures S1–S3 show the 
distribution of residential ambient air pollution concen-
trations. Mean (±SD) annual estimates of PM10, PM2.5 and 
NO2 were 91.11 (±28.95 μg/m
3), 54.02 (±17.02 μg/m3) 
and 28.97 (±22.42 μg/m3), respectively. NO2 concentra-
tions were highly correlated with PM2.5 (r=0.92), but less 
so with PM10.
Lung function and air pollution: full cohort
In the full cohort, including both non- COPD and COPD 
participants, an IQR increase in the 3- year moving 
average of all pollutants showed adverse associations 
with lung function (table 2). In adjusted models, an IQR 
increase in PM10 exposure was associated with lower FEV1 
(−29.08 mL, 95% CI –43.26 to –14.89) and FEV1/FVC ratio 
(−1.85, 95% CI −2.24 to –1.46). For each IQR increase in 
NO2, lower FEV1 (−60.12 mL, 95% CI –84.00 to –36.23) 
and FVC (−32.33 mL, 95% CI –56.35 to –8.32) was 
observed. Furthermore, results showed negative associ-
ations between PM2.5 concentrations and lung function, 
with stronger effects on FEV1 than FVC. The FEV1/FVC 
ratio showed no association with ambient NO2 exposure. 
For all pollutants, significant effect modification by BMI 
and lower household income was identified (all pinteract 
<0.001). For NO2 and PM10, older age (>65 years) was 
linked with lower FEV1. Associations were further inves-
tigated in non- COPD and COPD participants separately.
COPD and air pollution
Consistent with our findings for lung function, we found 
an IQR increase in the 3- year moving average of PM2.5 and 
PM10 to be associated with 35% and 24% increased prev-
alence odds ratio (POR) of COPD (POR 1.35, 95% CI 
1.26 to 1.43; POR 1.24, 95% CI 1.18 to 1.29), respec-
tively, when COPD status was treated as a binary outcome 
(figure 1). A nominally positive, non- significant, associa-
tion was observed for NO2. Effect modification for PM2.5 
was seen in former smokers (p=0.04).
Lung function and air pollution: non-COPD participants
In participants without COPD, an IQR increase in each 
pollutant showed significant inverse associations with 
FEV1 (PM10 −25.31, β 95% CI –36.81 to –13.8; PM2.5 
–53.81, β 95% CI –107.09 to –0.53; and NO2 −74.88, β 
95% CI –146.61 to –3.15). However, an IQR increment 
in 3- year moving averages of PM10, PM2.5 and NO2 was not 
significantly associated with FVC (table 3).
Lung function and air pollution: COPD participants
In participants with COPD, all pollutants were statisti-
cally significantly associated with decrements in FEV1 
and FVC. Additionally, the magnitude of association 
was more substantial than that found in non- COPD 
participants (table 3), with an IQR increase in PM10, 
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PM2.5 and NO2 associated with FEV1 −25.31 mL (95% CI 
–36.81 to –13.80), −53.81 mL (95% CI –107.09 to –0.53) 
and −74.88 mL (95% CI –146.61 to –3.15), respectively. 
Smaller magnitudes of association were observed in FVC 
measurement (table 3).
Results of PM10, PM2.5 and NO2 subgroup analyses for 
COPD and FEV1 are shown in tables 4 and 5, respectively. 
FEV1- stratified analyses showed stronger associations 
for PM10 and NO2 in older participants, subjects from 
lower- income households, and individuals with a history 
of asthma. The same effect modification patterns were 
observed for FVC- stratified analyses (data not shown). 
Participants from lower- income households had mean 
FEV1 levels three- to- five times lower than higher- income 
Table 1 Population baseline characteristics
No COPD±SD or % COPD±SD or % Total population Difference p value
NO2 (µg/m
3) 31.20 (12.86) 30.11 (10.07) 30.99 (12.36) 0.23
PM2.5 (µg/m
3) 55.38 (0.81) 58.65 (0.80) 56.02 (14.88) 0.10
PM10 (µg/m
3) 94.46 (1.19) 101.92 (1.39) 95.93 (27.61) 0.02
Age (years) 61.05 (8.57) 64.45 (9.59) 61.72 (8.89) 0.16
FVC (L) 2.34 (0.78) 2.30 (0.94) 2.33 (0.81) 0.05
FEV1 (L) 2.06 (0.02) 1.47 (0.03) 1.95 (0.78) 0.007
FEV1/FVC (%) 87.87 (8.28) 50.46 (20.02) 80.49 (18.88) 0.03
Height (cm) 159.45 (8.73) 158.63 (8.68) 159.29 (8.72) 0.56
BMI 24.26 (4.97) 23.60 (4.36) 24.13 (4.87) 0.81
Sex 0.57
  Male 4848 (49.24) 1207 (49.92) 6055 (49.37)
  Female 4998 (50.76) 1210 (50.08) 6209 (50.63)
Place or residence 0.85
  Urban 4173 (42.38) 1040 (43.02) 5213 (42.51)
  Rural 5673 (57.62) 1377 (56.98) 7051 (57.49)
Physical activity 0.004
  Low 2623 (76.97) 784.7 (23.03) 3407 (27.79)
  Moderate 2597 (81.43) 592.1 (18.57) 3189 (26.01)
  High 4624 (81.64) 1040 (18.36) 5664 (46.2)
Smoking status 0.34
  Never 6248 (80.86) 1479 (19.14) 7728 (63.28)
  Current 2943 (79.65) 752 (20.35) 3695 (30.26)
  Former 620.4 (78.57) 169.2 (21.43) 789.6 (6.466)
Asthma status 0
  No 9452 (80.92) 2228 (19.08) 11 692 (96.44)
  Yes 282.7 (65.49) 148.9 (34.51) 431.6 (3.56)
Annual household income (¥) 0.002
  ≤15 000 5065 (52.66) 1424 (60.89) 6489 (54.27)
  >15 000 4554 (47.34) 914.6 (39.11) 5468 (45.73)
Fuel used at home 0.44
  Clean 4787 (81.21) 1107 (18.79) 5894 (48.34)
  Unclean 5013 (79.57) 1287 (20.43) 6300 (51.66)
Level of education 0.07
  No formal education 4071 (41.61) 1080 (42.31) 5152 (42.31)
  Primary school 2047 (20.92) 502.1 (20.93) 2549 (20.93)
  Middle school 2127 (21.74) 418.4 (20.93) 2545 (20.91)
  College or higher 1540 (15.74) 390.6 (15.85) 1930 (15.85)
BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; NO2, nitrogendioxide; PM10, particulate matter 
with an aerodynamic diameter ≤10 μm; PM2.5, particulate matter with anaerodynamic diameter ≤2.5 μm.
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participants (all p<0.001); individuals with a history of 
asthma showed FEV1 levels lower than those with no 
previous history of asthma, per unit increase in PM10, 
PM2.5 or NO2, although the later findings did not reach 
statistical significance. In COPD subgroup analyses, NO2 
association was also found to be stronger among partici-
pants with asthma (p=0.003).
Our sensitivity analyses produced comparable effect 
estimates to our main models (online supplemental tables 
S3 and S4). When using different exposure windows and 
additionally adjusting for city- specific covariates, such as 
GDP, percentage of the population living in urban areas, 
similar effect estimates were observed. For instance, each 
IQR increase in the 1- year average concentration of PM10 
was associated with a reduction in FEV1 (β −34.44, 95% CI 
–46.09 to –22.79) and an increase in COPD prevalence by 
30% (POR 1.30, 95% CI 1.21 to 1.39). When excluding 
the participants with cardiovascular diseases, the models 
also produced consistent effect estimates (online supple-
mental tables S3 and S4).
DISCUSSION
Long- term exposure to higher concentrations of PM2.5 
and PM10 was associated with increased prevalence of 
COPD among older Chinese adults. Impaired lung func-
tion related to air pollution exposure was also observed. 
Reduced FEV1 was linked to all three pollutants; PM2.5 
and PM10 were additionally associated with decreased 
FEV1/FVC ratio, while NO2 was associated with lower 
FVC. We further found more significant magnitude effect 
estimates among participants with COPD, suggesting that 
this may be a particularly susceptible group to the delete-
rious pulmonary effects of air pollution.
COPD prevalence
Air pollution has been recognised as a likely risk factor 
for COPD, although only a small number of studies 
have investigated this association in China.21 A cross- 
sectional study of almost 6000 residents of Guangdong 
province showed statistically significant associations 
between elevated levels of PM2.5 and PM10 and increased 
prevalence of COPD.27 For daily mean PM2.5>75 mg/m
3 
and PM10 >50 to≤150 mg/m
3, the adjusted OR for COPD 
prevalence was 2.530 (95% CI 1.280 to 5.001) and 2.442 
(95% CI 1.449 to 4.117), respectively. Accordingly, the 
present population- based analysis showed 35% (POR 
1.35, 95% CI 1.26 to 1.43) and 24% (POR 1.24, 95% CI 
1.18 to 1.29) increase in COPD prevalence due to high 
exposure to PM2.5 and PM10, respectively. Presumably, the 
difference in prevalence is due to distinct distribution of 
study populations. Likewise, in a large- scale (n=2 85 046) 
longitudinal cohort with 13 years of follow- up, Guo et al 
found a higher incidence of COPD among those exposed 
to higher PM2.5 concentrations.
28
The negative effect of the long- term exposures to PM2.5 
and PM10 is further supported by the results from Western 
countries29 30; however, findings regarding COPD and air 
pollution are not consistent. For example, a meta- analysis 
of four large European cohorts did not demonstrate any 
significant associations between prevalence and inci-
dence of COPD and different air pollutants.31 We found 
no significant associations of COPD prevalence with NO2, 
which contradicts the findings from the UK Biobank 
study and a US cohort study.29 30
This heterogeneity in findings may be explained by 
different outcome and exposure assessments, or uncon-
trolled confounding in some studies. Most of the evidence 
supporting the positive association between NO2 and 
COPD incidence or prevalence is derived from research on 
the general population of adults from Western countries,32 
whereas we evaluated older adults from China. Also, the 


























*p<0.05. Models adjusted for age, sex, smoking status, daily tobacco consumption, physical activity, education, BMI, alcohol, place of 
residence, household income, type of indoor fuel use, daily fruit and vegetables consumption. IQR PM10: 3 years: 31.2 µg/m
3; IQR PM2.5: 
3 years: 26.1 µg/m3; IQR NO2: 3 years: 26.8 µg/m
3.
BMI, body mass index; NO2, nitrogen dioxide; PM10, particulate matter with an aerodynamic diameter less than or equal to 10 µm; PM2.5, 
particulate matter with an aerodynamic diameter less than or equal to 2.5 µm.
Figure 1 Association between chronic obstructive 
pulmonary disease prevalence ratio and ambient air 
pollution exposure.
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NO2 association may be more susceptible to confounding 
due to NO2 being primarily a traffic- related air pollutant 
with high spatial variation and people having a much 
greater variability in traffic- related pollution exposure than 
PM. Thus, geographic and population- related factors might 
have impacted the magnitude of the effect.
Lung function
Long- term exposure to air pollution has also been previ-
ously shown in some, but not all, studies to adversely 
affect lung function. Subjects from our cohort demon-
strated an obstructive pattern of lung function decline,33 
with significant associations between FEV1 reduction and 
PM2.5, PM10 and NO2 exposures, as well as FEV1/FVC 
decrease and exposure to PM2.5 and PM10. The associa-
tions we observed for FEV1 are broadly consistent with 
the outcomes reported by other studies from econom-
ically developing countries27 28 34 as well as some Euro-
pean studies.28 35–38 However, a meta- analysis of European 
multicentre cohort studies (ESCAPE) showed no associa-
tions between PM2.5 and decrements in FEV1.
35
Our findings regarding the decrease in FEV1/FVC 
ratio with increased PM exposure have also recently been 
reported in some Asian cohorts.27 28 34 Liu et al demonstrated 
0.09% (95% CI −0.170 to –0.010) and 0.024% (95% CI 
−0.092 to 0.040) declines in FEV1/FVC ratio for PM2.5 and 
PM10 exposure, respectively, among Chinese adult partici-
pants.27 A large longitudinal Taiwanese cohort showed a 
0.21% decrease in FEV1/FVC with 5 μg/m³ increment in 
PM2.5 with an annual decrease of 0.09%.
28 Interestingly, the 
UK Biobank Study found PM2.5, but not PM10, increment 
to be associated with FEV1/FVC decrease,
29 while another 
study from the UK failed to show significant associations 
between FEV1/FVC decline and PM10 exposure.
36
In contrast to most previous research,27–29 34 35 37 we did 
not find PM2.5 or PM10 to be associated with decrements 
in FVC. This disparity might be related to distinct demog-
raphy of our study population as well as differences in 
sources and chemical composition of PM.
The present results also indicated direct correlations 
between lower- income households (≤¥15 000) and 
decreased FEV1 for all three pollutants. This finding 
illustrates the enhanced effects of air pollution on low- 
income populations, which can be justified by higher 
exposure to common health risk factors, substandard 
living conditions, poorer nutrition, more frequent child-
hood infections and worse access to healthcare services.38 
Similar associations were previously displayed by other 
studies.26 29 In our analysis, PM10 and NO2 exposure were 
linked to lower FEV1 values in elderly individuals, which 
was also demonstrated previously.36 This might be a valu-
able complement to the list of other effect modification 
characteristics. For instance, some studies reported that 
the history of smoking, obesity or gender was associ-
ated with poorer outcomes,28 34 36 whereas healthy diet 
consisting of regular intake of fruits and vegetables miti-
gated the adverse effects from ambient air pollution.36
The discrepancies in the publications mentioned 
above may arise from several possible explanations. 
First, studies varied in the populations assessed and the 
geographic regions studied. The adjustment for poten-
tial confounders was not consistent in all studies, and it 
is not entirely clear to what extent it could have influ-
enced the outcomes. Second, the exposure assessment 
of the pollutants differed among cohorts, which might 
have also impacted the results. Third, in some publi-
cations, the heterogeneities between included studies 
and subgroups could have significantly contributed 
to the statistical insignificance. Fourth, differences in 
applied statistical methods (with their respective limita-
tions) might also have played a role in variation in the 
outcome assessment. Fifth, additive effects of co- pollut-
ants, which is highly likely to vary across world regions, 
could have influenced the magnitude of the associa-
tions within the various endpoints. Last, and possibly 
most importantly, almost no study assessed different 
phenotypes of COPD, which can be a critical factor for 
data stratification.































*p<0.05. Models adjusted for age, sex, smoking status, daily tobacco consumption, physical activity, education, BMI, alcohol, place of 
residence, household income, type of indoor fuel use, daily fruit and vegetables consumption. IQR PM10: 3 years: 31.2 µg/m
3; IQR PM2.5: 
3 years: 26.1 µg/m3; IQR NO2: 3 years: 26.8 µg/m
3.
BMI, body mass index ; NO2, nitrogen dioxide; PM10, particulate matter with an aerodynamic diameter less than or equal to 10 µm; PM2.5, 
particulate matter with an aerodynamic diameter less than or equal to 2.5 µm.
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COPD versus non-COPD
The negative impact of increased exposure to air pollut-
ants on the respiratory function was more pronounced in 
participants with COPD compared with those without the 
disease. One of the primary explanations for this finding 
is the fact that individuals with COPD have already 
decreased pulmonary physiological function.39 This 
group has a higher risk of developing other respiratory 
diseases, including airway infections and lung cancer, 
than the general population.21 Moreover, individuals 
with COPD often have other chronic comorbidities, such 
as cardiovascular disease, as well as mental or metabolic 
disorders.40 Studies showed that patients with COPD have 
elevated levels of specific inflammatory markers at the 
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baseline,31 which may play an essential role in the mech-
anisms and progression of the disease.41
To our knowledge, this is the first study to report the 
detrimental effects of long- term ambient air pollution 
on individuals with COPD in comparison to people 
without COPD. Previous research reported enhanced 
adverse effects from air pollutants on lung function in 
individuals with pre- existing chronic conditions, such as 
heart disease, asthma, diabetes, obesity or smoking.29 36 
Additionally, exposure to air pollution was demonstrated 
to increase the frequency of COPD exacerbations42 and 
mortality.8 An interesting finding was reported by Dorion 
et al, where subjects with occupations considered at 
risk for COPD (eg, coal mine operatives, chemical and 
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related process operatives) had three times lower levels 
of FEV1 and FVC per each unit increase in PM2.5 and NO2 
compared with those with other occupations.29 Forbes 
et al reported the effect modification for PM10, NO2 
and SO2 when excluding patients with asthma, emphy-
sema or bronchitis compared with the general cohorts.36 
However, no direct comparison between these groups 
was available.
Strengths and limitations
This study has several limitations. First, analyses are 
limited by the cross- sectional study design and offer little 
information on the longitudinal effects of evaluated 
pollutants. Second, differential physical activity patterns, 
changes in participant addresses and discriminatory infil-
tration of outdoor pollution to the indoor environment 
may have contributed to misclassification of exposure 
levels. Other potential confounding factors, including 
secondhand tobacco smoking, various environmental 
components and the impact of other air pollutants, were 
not assessed. Finally, further studies are warranted to 
investigate the effects of particulates of different sizes as 
well as other gaseous pollutants. These limitations are 
offset by some important strengths. The results of the 
current study are based on representative populations of 
adults from eight different provinces in China, whereas 
most previously published work has been focused on 
specific areas of the country. Additionally, we were able 
to adjust for many important confounders and estimated 
exposure using high- quality spatiotemporal air pollution 
exposure models.
Future research and conclusions
Although the link between outdoor air pollution and 
impaired respiratory function has been previously 
explored, discrepancies in the findings related to the 
type of pollutants and specific lung function parameters 
remain. Moreover, there is still a lack of data coming from 
low- income and middle- income countries. The popula-
tions of these countries are of particular interest as they 
are more often affected by both severe outdoor air pollu-
tion and chronic lung diseases, including COPD. The 
elderly population in Asian countries, including China, 
is one of the most vulnerable groups in this regard. Air 
pollution and COPD will continue to be major public 
health problems worldwide. Considering the ever- ageing 
global population, future research should focus on older 
participants with robust study design and powerful statis-
tical models. The influence of COPD phenotype should 
also be investigated in future studies.
In conclusion, this study contributes to the current 
evidence regarding the association between ambient 
air pollution and decreased lung function, as well as 
increased prevalence of COPD, among adults from devel-
oping countries. Our findings further indicate that indi-
viduals with COPD are more vulnerable to high levels of 
air pollutants with a higher risk of decline in respiratory 
function.
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